BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 21839519)

  • 1. Neisseria meningitidis and Escherichia coli are protected from leukocyte phagocytosis by binding to erythrocyte complement receptor 1 in human blood.
    Brekke OL; Hellerud BC; Christiansen D; Fure H; Castellheim A; Nielsen EW; Pharo A; Lindstad JK; Bergseth G; Leslie G; Lambris JD; Brandtzaeg P; Mollnes TE
    Mol Immunol; 2011 Sep; 48(15-16):2159-69. PubMed ID: 21839519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Key role of the number of complement receptor 1 on erythrocytes for binding of Escherichia coli to erythrocytes and for leukocyte phagocytosis and oxidative burst in human whole blood.
    Brekke OL; Christiansen D; Kisserli A; Fure H; Dahl JA; Donvito B; Reveil B; Ludviksen JK; Tabary T; Mollnes TE; Cohen JHM
    Mol Immunol; 2019 Oct; 114():139-148. PubMed ID: 31352230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of complement C3 opsonization, C5a receptor, and CD14 in E. coli-induced up-regulation of granulocyte and monocyte CD11b/CD18 (CR3), phagocytosis, and oxidative burst in human whole blood.
    Brekke OL; Christiansen D; Fure H; Fung M; Mollnes TE
    J Leukoc Biol; 2007 Jun; 81(6):1404-13. PubMed ID: 17389579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement activation and complement-dependent inflammation by Neisseria meningitidis are independent of lipopolysaccharide.
    Sprong T; Møller AS; Bjerre A; Wedege E; Kierulf P; van der Meer JW; Brandtzaeg P; van Deuren M; Mollnes TE
    Infect Immun; 2004 Jun; 72(6):3344-9. PubMed ID: 15155639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Essential role of the C5a receptor in E coli-induced oxidative burst and phagocytosis revealed by a novel lepirudin-based human whole blood model of inflammation.
    Mollnes TE; Brekke OL; Fung M; Fure H; Christiansen D; Bergseth G; Videm V; Lappegård KT; Köhl J; Lambris JD
    Blood; 2002 Sep; 100(5):1869-77. PubMed ID: 12176911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement coating of erythrocytes is reduced following their interaction with neutrophils in vitro without loss of complement receptor 1 (CR1).
    Imrie HJ; Jones DR
    Clin Exp Immunol; 1997 Jul; 109(1):217-22. PubMed ID: 9218847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Escherichia coli bound to the primate erythrocyte complement receptor via bispecific monoclonal antibodies are transferred to and phagocytosed by human monocytes in an in vitro model.
    Kuhn SE; Nardin A; Klebba PE; Taylor RP
    J Immunol; 1998 May; 160(10):5088-97. PubMed ID: 9590260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of C5a-induced inflammation with preserved C5b-9-mediated bactericidal activity in a human whole blood model of meningococcal sepsis.
    Sprong T; Brandtzaeg P; Fung M; Pharo AM; Høiby EA; Michaelsen TE; Aase A; van der Meer JW; van Deuren M; Mollnes TE
    Blood; 2003 Nov; 102(10):3702-10. PubMed ID: 12881318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The anti-lipid A monoclonal antibody E5 binds to rough gram-negative bacteria, fixes C3, and facilitates binding of bacterial immune complexes to both erythrocytes and monocytes.
    Seelen MA; Athanassiou P; Lynn WA; Norsworthy P; Walport MJ; Cohen J; Davies KA
    Immunology; 1995 Apr; 84(4):653-61. PubMed ID: 7790040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of selective complement and CD14 inhibition on the E. coli-induced tissue factor mRNA upregulation, monocyte tissue factor expression, and tissue factor functional activity in human whole blood.
    Brekke OL; Waage C; Christiansen D; Fure H; Qu H; Lambris JD; Østerud B; Nielsen EW; Mollnes TE
    Adv Exp Med Biol; 2013; 735():123-36. PubMed ID: 23402023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The roles of complement receptors type 1 (CR1, CD35) and type 3 (CR3, CD11b/CD18) in the regulation of the immune complex-elicited respiratory burst of polymorphonuclear leukocytes in whole blood.
    Nielsen CH; Antonsen S; Matthiesen SH; Leslie RG
    Eur J Immunol; 1997 Nov; 27(11):2914-9. PubMed ID: 9394818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional opsonic activity of human serum antibodies to inner core lipopolysaccharide (galE) of serogroup B meningococci measured by flow cytometry.
    Plested JS; Ferry BL; Coull PA; Makepeace K; Lehmann AK; MacKinnon FG; Griffiths HG; Herbert MA; Richards JC; Moxon ER
    Infect Immun; 2001 May; 69(5):3203-13. PubMed ID: 11292742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The primate erythrocyte complement receptor (CR1) as a privileged site: binding of immunoglobulin G to erythrocyte CR1 does not target erythrocytes for phagocytosis.
    Reinagel ML; Gezen M; Ferguson PJ; Kuhn S; Martin EN; Taylor RP
    Blood; 1997 Feb; 89(3):1068-77. PubMed ID: 9028340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phagocytosis of live and dead Escherichia coli and Staphylococcus aureus in human whole blood is markedly reduced by combined inhibition of C5aR1 and CD14.
    Skjeflo EW; Christiansen D; Landsem A; Stenvik J; Woodruff TM; Espevik T; Nielsen EW; Mollnes TE
    Mol Immunol; 2019 Aug; 112():131-139. PubMed ID: 31102985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human genetic deficiencies reveal the roles of complement in the inflammatory network: lessons from nature.
    Lappegård KT; Christiansen D; Pharo A; Thorgersen EB; Hellerud BC; Lindstad J; Nielsen EW; Bergseth G; Fadnes D; Abrahamsen TG; Høiby EA; Schejbel L; Garred P; Lambris JD; Harboe M; Mollnes TE
    Proc Natl Acad Sci U S A; 2009 Sep; 106(37):15861-6. PubMed ID: 19717455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement-independent adherence of Escherichia coli to complement receptors in vitro.
    Fine DP; Harper BL; Carpenter ED; Davis CP; Cavallo T; Guckian JC
    J Clin Invest; 1980 Sep; 66(3):465-72. PubMed ID: 6105165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced erythrocyte CR1 (CD 35) receptor function and complement opsonization in factor I-deficient patients is restored by plasma infusion.
    Jepsen HH; Teisner B; Rasmussen JM; Svehag SE
    Scand J Immunol; 1989 Feb; 29(2):247-55. PubMed ID: 2522236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defective complement receptors (CR1 and CR3) on erythrocytes and leukocytes of factor I (C3b-inactivator) deficient patients.
    Porteu F; Fischer A; Descamps-Latscha B; Halbwachs-Mecarelli L
    Clin Exp Immunol; 1986 Nov; 66(2):463-71. PubMed ID: 2949901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD14(hi)CD16+ monocytes phagocytose antibody-opsonised Plasmodium falciparum infected erythrocytes more efficiently than other monocyte subsets, and require CD16 and complement to do so.
    Zhou J; Feng G; Beeson J; Hogarth PM; Rogerson SJ; Yan Y; Jaworowski A
    BMC Med; 2015 Jul; 13():154. PubMed ID: 26149666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune complex-like moieties in immunoglobulin for intravenous use (i.v.Ig) bind complement and enhance phagocytosis of human erythrocytes.
    Shoham-Kessary H; Naot Y; Gershon H
    Clin Exp Immunol; 1998 Jul; 113(1):77-84. PubMed ID: 9697987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.